Moderna and Merck's mRNA cancer vaccine cuts death, recurrence by 42%
Late-stage win sets up regulatory talks and could reshape how cancer is treated - and how biotech investors value mRNA platforms.

Loading the Newsroom
Curating from trusted global sources…
82 briefings · “ark”
Late-stage win sets up regulatory talks and could reshape how cancer is treated - and how biotech investors value mRNA platforms.
A vulnerability in the code behind a large share of the web is triggering a worldwide scramble to patch, and it's a reminder that your stack's oldest dependencies can be its biggest risk.
The deal raises a key question: should companies cover executives' personal tax bills?
The first distribution in the landmark liquidation signals a near-total wipeout for everyone holding Chinese property credit.
Facing a possible California wealth tax, Meta's board restructured the company's shares to help Zuckerberg pay the bill.
European agencies from Belgium to Germany took websites dark to patch a critical weakness in the language behind almost 70% of the web, and the blast radius extends far beyond government portals.
Tesla will sell its autonomous two-seater by end of year while federal regulators investigate whether it meets vehicle safety standards.
Meta's new $150B share class gives Zuckerberg $20B in liquidity to cover the tax, but only if he stays put.
SpaceX will keep half its compute for internal AI projects and rent the rest at spot rates, betting the super-intelligence shortage will last.
Nvidia's DSX pods, fully wired modular containers, promise to shrink AI factory deployment from six months to two weeks, starting with Vera Rubin systems in 2027.
Australia's leading data center operator just lost two-fifths of its market value over power problems, a warning shot for every digital infrastructure executive.
The server maker says revenue and profit could land far above guidance, lifting the whole AI hardware complex and raising stakes for upcoming earnings.